TIFFANY CASHDOLLAR: Open Payments
NPI 1992562151 · KITTANNING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 64 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $722 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $300 |
| ABBVIE INC. | 12 | $223 |
| Lilly USA, LLC | 8 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $102 |
| Phathom Pharmaceuticals, Inc. | 5 | $93 |
| Amgen Inc. | 5 | $89 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Exact Sciences Corporation | 3 | $48 |
| PFIZER INC. | 2 | $45 |
| Impel Pharmaceuticals LLC | 1 | $23 |
Products named: JARDIANCE, QULIPTA, MOUNJARO, Wegovy, VOQUEZNA, TRELEGY ELLIPTA, UBRELVY, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
